We present the case of a patient with granulomatosis with polyangiitis (GPA) treated with rituximab, who was diagnosed with coronavirus disease 2019 (COVID-19). Following an index hospitalization with apparent resolution of the infection, the patient was readmitted with clinical deterioration. While repeat serial real-time polymerase chain reaction (rt-PCR) from nasopharyngeal swabs were negative, a bronchoalveolar lavage (BAL) sample demonstrated persistent COVID-19 to be the etiologic factor. Administration of convalescent plasma led to remarkable recovery.
No takes yet. Share an insight, caveat, or question.
Kessler et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: